The U.S. unit of Indian drugmaker Dr. Reddy’s Laboratories is recalling 331,590 bottles of cinacalcet tablets used to treat hyperparathyroidism due to the presence of a known carcinogen. | The U.S.
Thyroid cancer symptoms can often be mistaken for other conditions, leading to a delay in diagnosis, so the NHS reminds Brits to be particularly aware of a sore throat and difficulty swallowing ...
The approval of Ascendis Pharma A/S’ hormone replacement therapy Yorvipath (palopegteriparatide) hypoparathyroidism – the first and only treatment for adults with the rare endocrine disease – did ...
compared to users of other diabetes medications. “We took the innovative approach of applying the methodological rigor of a randomized clinical trial to the very large dataset of observational studies ...